Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Tablets: SOP for Intermediate Precision Testing for Tablets – V 2.0

Posted on By

Tablets: SOP for Intermediate Precision Testing for Tablets – V 2.0

Standard Operating Procedure for Intermediate Precision Testing for Tablets

Department Quality Control
SOP No. SOP/TAB/111/2025
Supersedes SOP/TAB/111/2022
Page No. Page 1 of 7
Issue Date 01/03/2026
Effective Date 06/03/2026
Review Date 01/03/2027

1. Purpose

To define the procedure for performing intermediate precision testing of analytical methods for tablets, ensuring that the method is consistent and reproducible under different operational conditions.

2. Scope

This SOP applies to intermediate precision testing of analytical methods used for tablet formulations, including methods like HPLC, UV-Vis spectroscopy, and GC. It ensures that the testing process yields consistent results when conducted by different operators and at different times.

3. Responsibilities

  • Quality Control (QC): Responsible for performing intermediate precision testing and ensuring that the method meets the required precision specifications.
  • Quality Assurance (QA): Ensures that intermediate precision testing is performed according to the SOP and reviews the results for compliance with regulatory standards.
  • Laboratory Personnel: Responsible for conducting intermediate precision testing, ensuring consistency in the results, and maintaining proper documentation.

4. Accountability

The QC Manager is accountable for ensuring that intermediate precision testing is performed accurately and in compliance with regulatory requirements. The QA Manager is responsible for

reviewing and approving the results to ensure consistency and reliability.

See also  Tablets: SOP for End-Point Determination in Granulation Process - V 2.0

5. Procedure

5.1 Test Preparation

  1. Review the analytical method to be tested for intermediate precision (e.g., HPLC, UV-Vis, or GC).
  2. Obtain a representative sample of the tablet formulation for testing.
  3. Prepare the sample and solutions as per the analytical method’s requirements.
  4. Ensure that the laboratory equipment and instruments (e.g., HPLC system, UV-Vis spectrophotometer) are calibrated and functioning properly before starting the tests.

5.2 Selection of Operators

  1. Choose at least two qualified laboratory personnel who will perform the testing independently to ensure operator variability.
  2. Ensure that both operators are trained in the same method and use the same procedure for testing, but perform the tests at different times and possibly under different conditions (e.g., different equipment setups, different shifts).

5.3 Intermediate Precision Testing Procedure

  1. Perform the analysis for the tablet sample using the selected analytical method (e.g., HPLC, UV-Vis, or GC) according to the method’s standard operating procedure.
  2. Have each operator conduct the analysis at separate times to account for variability in the method. Ensure that the same set of samples and conditions is used for each test.
  3. Each operator should perform multiple replicate tests (usually 6–10) per condition to assess precision.
  4. Record all relevant data, including sample preparation, instrument settings, and results of the analysis.

5.4 Data Analysis

  1. Calculate the mean, standard deviation, and coefficient of variation (CV) for the results obtained by each operator.
  2. Compare the variability between the two operators. The data should be evaluated using the following criteria:
    • The CV for each operator should not exceed a predefined limit (usually 2%–5%, depending on the method and specifications).
    • The difference in mean results between operators should be minimal, indicating consistency.
  3. If the CV for either operator exceeds the predefined limit, further investigation should be carried out to determine the cause of the inconsistency.
See also  Tablets: SOP for Real-Time Sampling Plans in Tablet Compression - V 2.0

5.5 Acceptance Criteria

  1. The analytical method is considered to have passed the intermediate precision test if the variation between the results from both operators is within the acceptable limits (e.g., CV <5%).
  2. If the test results do not meet the acceptance criteria, investigate the reasons for the failure and perform corrective actions (e.g., retraining of operators, equipment maintenance, or recalibration).

5.6 Documentation and Record-Keeping

  1. Document all intermediate precision testing results, including the data from each operator, statistical calculations, and any deviations from the expected results in the batch record (Annexure-2).
  2. Ensure that all records are signed, dated, and stored according to the company’s record retention policy for future audits and inspections.
  3. Maintain raw data, including chromatograms, spectra, and test reports, for regulatory compliance and future reference.

5.7 Post-Test Actions

  1. Clean the laboratory equipment and instruments after each use to avoid cross-contamination between tests.
  2. Dispose of any used samples, reagents, or solvents according to the company’s waste disposal procedures.
  3. Ensure that the analytical instruments are regularly calibrated and maintained according to the manufacturer’s instructions and company SOPs.
See also  Tablets: SOP for Adhesion Testing of Enteric Coating During Coating - V 2.0

6. Abbreviations

  • SOP: Standard Operating Procedure
  • GMP: Good Manufacturing Practice
  • QC: Quality Control
  • QA: Quality Assurance
  • CV: Coefficient of Variation
  • HPLC: High-Performance Liquid Chromatography
  • UV-Vis: Ultraviolet-Visible Spectroscopy
  • GC: Gas Chromatography

7. Documents

  1. Batch Record (Annexure-2)
  2. Deviation Report (Annexure-1)

8. References

  • USP <621> – Chromatography
  • 21 CFR Part 211 – Current Good Manufacturing Practice for Finished Pharmaceuticals (US FDA)
  • European Pharmacopoeia (EP) – Specifications for Chromatography and Method Validation

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Deviation Report

Deviation Date Batch Number Deviation Description Corrective Action Responsible Person
15/12/2025 Batch 001 High variability in operator results Retrained operators and recalibrated equipment John Doe

Annexure-2: Batch Record

Batch Number Operator 1 Result Operator 2 Result Mean Result CV (%) Pass/Fail
Batch 001 98.0% 97.8% 97.9% 0.2% Pass

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/01/2024 1.0 Initial Version New SOP Creation QA Head
01/02/2025 2.0 Updated Data Analysis Method Improved method consistency QA Head
Tablet Manufacturing V2.0 Tags:GMP tablet manufacturing SOP, SOP for tablet production, SOP for tablet quality control, SOP tablet inspection process, SOP tablet packing and sealing, Tablet batch record review, Tablet blending SOP, Tablet cleaning and maintenance, Tablet coating procedure, Tablet compression SOP, Tablet disintegration test procedure, Tablet dissolution procedure, Tablet formulation SOP, Tablet friability testing SOP, Tablet labeling and packaging SOP, Tablet manufacturing equipment SOP, Tablet manufacturing SOP, Tablet manufacturing SOPs, Tablet packaging SOP, Tablet production procedure, Tablet quality assurance SOP, Tablet quality control SOP, Tablet sampling and in-process testing SOP, Tablet stability testing SOP, Tablet storage and handling procedure, Tablet uniformity testing procedure, Tablet weight variation SOP

Post navigation

Previous Post: Capsule: SOP for Cross-Contamination Prevention During Dispensing – V 2.0
Next Post: Capsule: SOP for Cleaning Dispensing Equipment – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version